Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmissi...
محفوظ في:
| المؤلف الرئيسي: | Mokhbat, Jacques (author) |
|---|---|
| التنسيق: | article |
| منشور في: |
2018
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/10475 https://doi.org/10.1016/S2468-1253(18)30056-6 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.sciencedirect.com/science/article/pii/S2468125318300566 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen
حسب: Mokhbat, J.
منشور في: (2008) -
Prevalence of hepatitis C virus isolate genotypes from chronically infected Lebanese patients
حسب: Mokhbat, J.
منشور في: (2003) -
Prevalence of hepatitis B and C viruses among migrant workers in Qatar
حسب: Gheyath K. Nasrallah (9200525)
منشور في: (2024) -
Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
حسب: Houssein H Ayoub (17704359)
منشور في: (2019) -
Exposure rates to hepatitis C and G virus infections among HIV-infected patients
حسب: Mokhbat, J.
منشور في: (2004)